These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1676772

  • 1. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage I-II preparations in the therapy of internal diseases].
    Grebnev AL, Miagkova LP, Kkhorshed AM.
    Klin Med (Mosk); 1991 Mar; 69(3):23-7. PubMed ID: 1676772
    [No Abstract] [Full Text] [Related]

  • 2. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP, Grebenev AL, Kkhorshed AM.
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Histamine H2-receptor antagonists.
    Keithley JK.
    Nurs Clin North Am; 1991 Jun; 26(2):361-73. PubMed ID: 1675461
    [Abstract] [Full Text] [Related]

  • 5. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical effects and problems; histamine H2 receptor blockaders].
    Tani N, Miwa T.
    Nihon Rinsho; 1988 Jan; 46(1):12-7. PubMed ID: 2897482
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Mechanism of recurrence and relapse in peptic ulcer after drug therapy; gastric juice and gastric acid secretion].
    Nakaizumi A, Iishi H, Tatsuta M, Okuda S.
    Nihon Rinsho; 1988 Jan; 46(1):102-6. PubMed ID: 2897480
    [No Abstract] [Full Text] [Related]

  • 8. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
    de Bruijne JW, Lamers CB.
    Ned Tijdschr Geneeskd; 1989 Apr 01; 133(13):657-62. PubMed ID: 2566125
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Controversies, dilemmas, and dialogues. Reduction of gastric acidity in the treatment of peptic ulcer disease: how low should we go?
    Peterson WL, Harford WV.
    Am J Gastroenterol; 1991 Jun 01; 86(6):671-5. PubMed ID: 1674838
    [No Abstract] [Full Text] [Related]

  • 12. Food and H2 blockade.
    Lancet; 1988 Aug 27; 2(8609):488-9. PubMed ID: 2900407
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Gastric secretion blockaders in peptic ulcer].
    Arutionian VM, Minasian GA.
    Sov Med; 1989 Aug 27; (7):45-8. PubMed ID: 2572058
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The use of histamine H2 receptor blockaders in gastroenterology].
    Waldum HL, Petersen H.
    Tidsskr Nor Laegeforen; 1983 Apr 30; 103(12):980-3. PubMed ID: 6136102
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Mechanism of action and therapeutic effectiveness of histamine H2 receptor blockaders in peptic ulcer].
    Glubochenko VG, Shcherbak VV.
    Vrach Delo; 1985 Feb 30; (2):13-5. PubMed ID: 2859701
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.